We serve N-(2-cyano-4-oxochromen-8-yl)-4-(4-phenylbutoxy)benzamide CAS:136450-11-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: N-(2-cyano-4-oxochromen-8-yl)-4-(4-phenylbutoxy)benzamide
CAS.NO: 136450-11-8
Synonyms:
Benzamide, N-(2-cyano-4-oxo-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-
Molecular Formula:C4H2BrClN2
Molecular Weight:193.42900
Physical and Chemical Properties:
Density: 1.3g / cm3
Boiling point: 574.009ºC at 760 mmHg
Melting point: /
Flash point: 301.0±30.1 °C
Refractive index: 1.651
Specification:
Appearance: White or off-white powder
Purity:≥99%
Residue on ignition:≤0.1%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Pranlukast CAS:103177-37-3
Contact us for information like N-(2-cyano-4-oxochromen-8-yl)-4-(4-phenylbutoxy)benzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzamide, N-(2-cyano-4-oxo-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(2-cyano-4-oxochromen-8-yl)-4-(4-phenylbutoxy)benzamide Use and application,N-(2-cyano-4-oxochromen-8-yl)-4-(4-phenylbutoxy)benzamide technical grade,usp/ep/jp grade.
Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.4-(4-chlorobutyl)pyridine,hydrochloride manufacturer We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.N-methyl-2,4-dinitroaniline supplier The news comes after China’s National Health Commission issued a notice on the treatment of the coronavirus on Monday, asking medical institutions to “actively promote the role of traditional Chinese medicine (TCM) during treatment.”4-Butylphenylboronic acid vendor The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.
